Roy reported relationships with ArteraAI, Merck, Varian Medical Systems, the Prostate Cancer Foundation, and Swim Across America. Posadas reported relationships with Bayer, Enviro Therapeutics ...

Although the concept of artificial intelligence (AI) dates back decades, it is only in the past decade that oncologists have begun encountering AI and potential AI involvement in clinical care on a ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

Ethan Varian is a Bay Area News Group reporter covering housing for The Mercury News and East Bay Times. He was previously a housing and homelessness reporter at the Santa Rosa Press Democrat in ...

Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...

The actor played Elaine Benes' hilariously eccentric boss, Mr. Peterman, at a fictional version of the real-life company John Russell is a Writer/Reporter at PEOPLE. He joined the PEOPLE team in ...

Johnson & Johnson begins a two-week trial on Feb. 18 over its plan to end tens of thousands of lawsuits filed by women or their family members who claim its baby powder gave them cancer.

Oncolytics (ONCY) Biotech continues to make good progress in 2025 with key regulatory and clinical advancements, reinforcing pelareorep’s potential in hard-to-treat cancers. Oncolytics ...

NEW YORK (Reuters) -Johnson & Johnson faces a critical test on Tuesday over its $10 billion proposal to end litigation alleging that its baby powder caused ovarian cancer, as it tries to convince ...